Literature DB >> 9205539

Pulmonary hypertension: updating a mysterious disease.

M Rabinovitch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9205539     DOI: 10.1016/s0008-6363(97)00053-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  7 in total

1.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 2.  A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation.

Authors:  You-Yang Zhao; Asrar B Malik
Journal:  Trends Cardiovasc Med       Date:  2009-10       Impact factor: 6.677

3.  Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.

Authors:  Rong Jiang; Zi-Sheng Ai; Xin Jiang; Ping Yuan; Dong Liu; Qin-Hua Zhao; Jing He; Lan Wang; Mardi Gomberg-Maitland; Zhi-Cheng Jing
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

4.  Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries.

Authors:  Mikiyasu Shirai; James T Pearson; Akito Shimouchi; Noritoshi Nagaya; Hirotsugu Tsuchimochi; Ishio Ninomiya; Hidezo Mori
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

5.  High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression.

Authors:  Devon Scott; Yan Tan; Robin Shandas; Kurt R Stenmark; Wei Tan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-19       Impact factor: 5.464

6.  Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.

Authors:  Makoto Sahara; Masataka Sata; Toshihiro Morita; Yasunobu Hirata; Ryozo Nagai
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 7.  Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.

Authors:  Ayodeji Adegunsoye; Matthew Levy; Olusegun Oyenuga
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.